
INDIGO Biosciences Launches Dopamine Receptor D1 Reporter Assay for Neurological and Psychiatric Research
New Cell-Based Assay Supports Drug Discovery for DRD1-Targeted Therapies STATE COLLEGE, PA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- INDIGO Biosciences, a premier provider of cell-based assay solutions, has introduced its Human Dopamine …